TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
NERV

Minerva Neurosciences Inc

Healthcare · Biotechnology

3.40$ +0.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Minerva Neurosciences Inc (NERV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13,511 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NERV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-36 -24 -26 3.1 -42 -43 -34 -25 -25 -15 -20 -13,511
0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 5.4
18 2.2 3.6 5.0 8.2 9.2 9.7 5.2 4.1 2.0 1.3 1,327
18 2.4 3.6 -4.3 8.2 26 9.7 25 12 – – –
1.0 0.0 1.3 39 0.1 3.4 -46 0.3 -4.1 4.9 -0.3 -0.6
0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
1.1 -18 18 -107 69 14 25 0.0 0.0 – – –
0.0 0.0 0.0 10 – – – – – – – –
52 31 21 0.0 0.7 0.5 13 – – – – –
10 10 -1.6 -4.9 -4.0 – – – – – – –
52 38 77 47 -3.3 0.5 13 60 0.0 20 0.0 74,451
17 -4.3 69 -57 24 -29 3.9 35 -25 4.8 -20 60,940
-36 -24 -26 3.0 -42 -43 -34 -25 -25 -15 -20 -13,511

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?